Loading...

Advanced mRNA And Oncology Programs Will Unlock Global Healthcare Demand

Published
13 Apr 25
Updated
07 May 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-6.8%
7D
-0.7%

Author's Valuation

US$169.9339.3% undervalued intrinsic discount

AnalystHighTarget Fair Value

Shared on 07 May 25

Fair value Increased 11%

Advanced mRNA And Oncology Programs Will Unlock Global Healthcare Demand

Shared on 30 Apr 25

Fair value Decreased 1.07%

Long-term Secular Trends Will Unlock mRNA And Oncology Breakthroughs

AnalystHighTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

Fair value Increased 9.72%

Long-term Secular Trends Will Unlock mRNA And Oncology Breakthroughs

AnalystHighTarget made no meaningful changes to valuation assumptions.

Shared on 16 Apr 25

Fair value Decreased 18%

Long-term Secular Trends Will Unlock mRNA And Oncology Breakthroughs

AnalystHighTarget made no meaningful changes to valuation assumptions.